Research library: Diabetes / Obesity
2009:
| December
| November
| October
| September
| August
| July
| May
| April
| February
Other Years: 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008
December
letter
Regulation of adaptive behaviour during fasting by hypothalamic Foxa2
Jose P. Silva et al.
Nature 462, 646650
(03 December 2009); doi:10.1038/nature08589
| Full Text (HTML / PDF) |
November
letter
Foxo1 integrates insulin signaling with mitochondrial function in the liver
Zhiyong Cheng et al.
Nature Medicine 15, 13071311
(November 2009); doi:10.1038/nm.2049
| Summary | Full Text (HTML / PDF) |
October
article
The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake
Leona Plum et al.
Nature Medicine 15, 11951201
(October 2009); doi:10.1038/nm.2026
| Summary | Full Text (HTML / PDF) |
article
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Jonathan W Day et al.
Nature Chemical Biology 5, 749757
(October 2009); doi:10.1038/nchembio.209
| Summary | Full Text (HTML / PDF) |
September
letter
A crucial role for adipose tissue p53 in the regulation of insulin resistance
Tohru Minamino et al.
Nature Medicine 15, 10821087
(September 2009); doi:10.1038/nm.2014
| Summary | Full Text (HTML / PDF) |
news and views
Connecting obesity, aging and diabetes
Rexford S. Ahima
Nature Medicine 15, 996997
(September 2009); doi:10.1038/nm0909-996
| Full Text (HTML / PDF) |
August
letter
The CDK4–pRB–E2F1 pathway controls insulin secretion
Jean-Sébastien Annicotte et al.
Nature Cell Biology 11, 10171023
(August 2009); doi:10.1038/ncb1915
| Summary | Full Text (HTML / PDF) |
July
letter
The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis
Yiguo Wang, Liliana Vera, Wolfgang H. Fischer & Marc Montminy
Nature 460, 534537
(23 July 2009); doi:10.1038/nature08111
| Full Text (HTML / PDF) |
review
The genetic contribution to non-syndromic human obesity
Andrew J. Walley, Julian E. Asher & Philippe Froguel
Nature Reviews Genetics 10, 431442
(July 2009); doi:10.1038/nrg2594
| Summary | Full Text (HTML / PDF) |
May
review
Assessing the potential of glucokinase activators in diabetes therapy
Franz M. Matschinsky
Nature Reviews Drug Discovery 8, 399416
(May 2009); doi:10.1038/nrd2850
| Summary | Full Text (HTML / PDF) |
review
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Bo Ahrén
Nature Reviews Drug Discovery 8, 369385
(May 2009); doi:10.1038/nrd2782
| Summary | Full Text (HTML / PDF) |
perspective
Therapeutic targets to reduce cardiovascular disease in type 2 diabetes
Cyrus DeSouza & Vivian Fonseca
Nature Reviews Drug Discovery 8, 361367
(May 2009); doi:10.1038/nrd2872
| Summary | Full Text (HTML / PDF) |
review
Targeting the CNS to treat type 2 diabetes
Darleen A. Sandoval, Silvana Obici & Randy J. Seeley
Nature Reviews Drug Discovery 8, 386398
(May 2009); doi:10.1038/nrd2874
| Summary | Full Text (HTML / PDF) |
April
review
Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
John D. Baxter & Paul Webb
Nature Reviews Drug Discovery 8, 308320
(April 2009); doi:10.1038/nrd2830
| Summary | Full Text (HTML / PDF) |
letter
Inactivation of the Fto gene protects from obesity
Julia Fischer et al.
Nature 458, 894898
(16 April 2009); doi:10.1038/nature07848
| Summary | Full Text (HTML / PDF) |
letter
Role of Jhdm2a in regulating metabolic gene expression and obesity resistance
Keisuke Tateishi, Yuki Okada, Eric M. Kallin & Yi Zhang
Nature 458, 757761
(09 April 2009); doi:10.1038/nature07777
| Summary | Full Text (HTML / PDF) |
article
Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks
Xia Yang et al.
Nature Genetics 41, 415423
(April 2009); doi:10.1038/ng.325
| Summary | Full Text (HTML / PDF) |
February
letter
Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
Bing Luan et al.
Nature 457, 11461149
(26 February 2009); doi:10.1038/nature07617
| Summary | Full Text (HTML / PDF) |
article
AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency
Kathy Jaworski et al.
Nature Medicine 15, 159168
(February 2009); doi:10.1038/nm.1904
| Summary | Full Text (HTML / PDF) |
|